• Dehydroabietic Acid in Precision Adipocyte Modulation Resear

  2026-05-09

  Explore how Dehydroabietic acid functions as a dual PPAR-α/γ agonist for advanced metabolic disorder research. This article uniquely analyzes its role in targeted adipocyte modulation and practical assay optimization.

• Canagliflozin Remodels Mitochondria in Diabetic Kidney Disea

  2026-05-08

  This study demonstrates that canagliflozin, a potent SGLT2 inhibitor, promotes both structural and bioenergetic improvements in proximal tubular cell mitochondria in hypertensive–diabetic mice. The findings suggest that canagliflozin’s renoprotective effects extend beyond glycemic control, providing a mechanistic foundation for its use in diabetes and kidney disease research.

• URB597 (KDS-4103): Dissecting FAAH Inhibition Beyond Neuropl

  2026-05-08

  Explore how URB597, a potent FAAH inhibitor, enables rigorous mechanistic dissection of endocannabinoid signaling, with a focus on experimental precision and translational relevance. This unique review moves beyond neuroplasticity to illuminate novel assay design strategies for in vivo FAAH inhibition and neuroinflammation studies.

• Mapping GCGR Small-Molecule Binding: Insights from MK 0893 C

  2026-05-07

  This study leverages crystallographic and dynamic structural data to delineate binding sites of small-molecule glucagon receptor antagonists, notably MK 0893. By systematically docking and simulating multiple clinical candidates, the work advances our understanding of GCGR modulation and provides a foundation for rational drug design targeting type 2 diabetes.

• Araucarene Diterpenes Promote β Cell Regeneration and Glucos

  2026-05-07

  This study from Xiamen University and collaborators identifies 16 araucarene diterpenes from Agathis dammara, including 11 new compounds, and demonstrates their hypoglycemic effects in a zebrafish model. The research reveals that these diterpenes promote pancreatic β cell regeneration and enhance glucose uptake, offering mechanistic insights relevant to diabetes research.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract

  2026-05-06

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents proteolytic degradation during protein extraction without interfering with divalent cation-dependent workflows. It is appropriate for Western blotting, co-immunoprecipitation, and kinase assays, but should not be used where EDTA-sensitive metalloprotease inhibition is required.

• Stiripentol: LDH Inhibitor for Epilepsy & Metabolic Assays

  2026-05-06

  Stiripentol offers precise, noncompetitive LDH inhibition for advanced epilepsy and immunometabolic research. Its solubility profile and validated workflow parameters make it a trusted choice for dissecting lactate metabolism in cellular and animal models.

• Imatinib (STI571): Precision Kinase Inhibition Meets Next-Ge

  2026-05-05

  Explore Imatinib (STI571)'s role as a selective tyrosine kinase inhibitor in cancer biology research, with unique insights into advanced mass spectrometry imaging technologies. Discover protocol nuances, reference-backed best practices, and the evolving landscape of kinase pathway interrogation.

• Tolazoline in Functional Islet Assays: Assay Optimization &

  2026-05-05

  Explore the nuanced role of Tolazoline as an α2-adrenergic receptor antagonist in advanced islet function and airway research. This article delivers a protocol-focused, evidence-labeled guide for optimizing assay performance, grounded in recent mechanistic discoveries.

• Triacetin Digestion: Hepatic Metabolic Regulation via SCTG A

  2026-05-04

  This study clarifies the digestion and absorption pathway of triacetin, a short-chain triacylglycerol (SCTG), in a rat model. The work elucidates how triacetin-derived acetic acid modulates hepatic energy metabolism, offering new mechanistic insight into the metabolic roles of SCTGs and their potential as dietary modulators.

• CHIR 99021 Trihydrochloride: Orchestrating Organoid Diversit

  2026-05-04

  Explore how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor from APExBIO, is revolutionizing translational research by enabling dynamic control over stem cell fate and organoid diversity. This thought-leadership article blends mechanistic insight, experimental guidance, and strategic context—grounded in the latest literature—to help translational researchers optimize protocol design and unlock new biological complexity in organoid systems.

• Determining α2-Adrenergic Receptor Binding via Open-Tubular

  2026-05-03

  This study introduces an innovative open-tubular capillary electrochromatography (CEC) method with partial capillary coating to accurately quantify the binding constants between α2-adrenergic receptors and seven drug compounds. The approach minimizes protein consumption and supports high-throughput binding affinity assays, with implications for receptor-targeted pharmacology and compound screening.

• CCL7+ Macrophages and Immunotherapy Resistance in Colorectal

  2026-05-02

  This study reveals that CCL7-expressing tumor-associated macrophages (TAMs) drive resistance to immune checkpoint inhibitors in colorectal cancer (CRC) by modulating immune cell infiltration and function. Targeting CCL7 in TAMs enhances CD8+ T cell infiltration and boosts the efficacy of anti-PD-L1 therapy, providing a mechanistic rationale for new combination immunotherapy strategies.

• Indazole/Indole Glucagon Receptor Antagonists for Diabetes C

  2026-05-01

  This study introduces a new series of indazole- and indole-based glucagon receptor antagonists designed to improve glycemic control in type 2 diabetes models. By systematically modifying the core scaffold derived from MK 0893, the researchers identified compounds with potent in vitro activity and demonstrated oral efficacy in humanized mouse models.

• A23187, Free Acid: Advanced Insights for Calcium-Mediated Ap

  2026-05-01

  Explore how A23187, free acid—a potent calcium ionophore—enables precise modulation of intracellular calcium and apoptosis pathways. This article offers advanced assay design insights, practical protocol parameters, and a critical bridge between mechanistic depth and translational application.

16450 records 1/1097 page Next 12345 下5页 Last page